Impaired high-density lipoprotein anti-oxidant capacity in human abdominal aortic aneurysm.
暂无分享,去创建一个
J. Michel | P. Rossignol | L. Louedec | J. Martín-Ventura | O. Meilhac | G. Leséche | T. Dejouvencel | Z. Lamiral | S. Delbosc | D. Diallo | G. Lesèche
[1] J. Egido,et al. Statin use in aortic aneurismal disease to prevent progression and cardiovascular events: review of experimental and clinical data C. , 2013, Current vascular pharmacology.
[2] F. Moll,et al. Intraluminal abdominal aortic aneurysm thrombus is associated with disruption of wall integrity. , 2013, Journal of vascular surgery.
[3] B. Baxter,et al. Elevation of Plasma High-Density Lipoproteins Inhibits Development of Experimental Abdominal Aortic Aneurysms , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[4] J. Golledge,et al. Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model. , 2012, The American journal of pathology.
[5] J. Wojta,et al. Simvastatin decreases free radicals formation in the human abdominal aortic aneurysm wall via NF-κB. , 2012, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[6] E. Eren,et al. High Density Lipoprotein and it’s Dysfunction , 2012, The open biochemistry journal.
[7] J. Michel,et al. Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: Detoxifying mechanisms and potential therapeutic options , 2012, Thrombosis and Haemostasis.
[8] Y. Okita,et al. Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats. , 2012, Journal of vascular surgery.
[9] S. Pennathur,et al. Myeloperoxidase Targets Apolipoprotein A-I, the Major High Density Lipoprotein Protein, for Site-Specific Oxidation in Human Atherosclerotic Lesions* , 2012, The Journal of Biological Chemistry.
[10] J. Michel,et al. Proteomic Analysis of Polymorphonuclear Neutrophils Identifies Catalase as a Novel Biomarker of Abdominal Aortic Aneurysm: Potential Implication of Oxidative Stress in Abdominal Aortic Aneurysm Progression , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[11] A. Kontush,et al. Biological activities of HDL subpopulations and their relevance to cardiovascular disease. , 2011, Trends in molecular medicine.
[12] M. Haas,et al. Inflammation, high-density lipoprotein and cardiovascular dysfunction , 2011, Current opinion in infectious diseases.
[13] Naihao Lu,et al. Effects of glutathione, Trolox and desferrioxamine on hemoglobin-induced protein oxidative damage: anti-oxidant or pro-oxidant? , 2011, European journal of pharmacology.
[14] J. Michel,et al. Identification of Peroxiredoxin-1 as a Novel Biomarker of Abdominal Aortic Aneurysm , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[15] Robert J. Hinchliffe,et al. Pathophysiology and epidemiology of abdominal aortic aneurysms , 2011, Nature Reviews Cardiology.
[16] Jean-Baptiste Michel,et al. Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans , 2010, Cardiovascular research.
[17] Abigail S Haka,et al. Mechanism of ceroid formation in atherosclerotic plaque: in situ studies using a combination of Raman and fluorescence spectroscopy. , 2011, Journal of biomedical optics.
[18] H. Takagi,et al. Serum high-density and low-density lipoprotein cholesterol is associated with abdominal aortic aneurysm presence: a systematic review and meta-analysis. , 2010, International angiology : a journal of the International Union of Angiology.
[19] E. Nilsson,et al. HDL in humans with cardiovascular disease exhibits a proteomic signature. , 2010, Clinica chimica acta; international journal of clinical chemistry.
[20] K. Jamrozik,et al. Association between serum lipoproteins and abdominal aortic aneurysm. , 2010, The American journal of cardiology.
[21] N. Fukagawa,et al. Age-related changes in redox signaling and VSMC function. , 2010, Antioxidants & redox signaling.
[22] Jean-BaptisteMichel,et al. Hemorphin 7 Reflects Hemoglobin Proteolysis in Abdominal Aortic Aneurysm , 2010 .
[23] A. Burlingame,et al. HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] K. Rye,et al. High-density lipoproteins, inflammation and oxidative stress. , 2009, Clinical science.
[25] A. Nègre-Salvayre,et al. Caveolin-1 sensitizes vascular smooth muscle cells to mildly oxidized LDL-induced apoptosis. , 2008, Biochemical and biophysical research communications.
[26] A. Nègre-Salvayre,et al. Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity. , 2008, Atherosclerosis.
[27] E. Schaefer,et al. Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction. , 2007, The American journal of cardiology.
[28] R. Keep,et al. A New Hippocampal Model for Examining Intracerebral Hemorrhage-Related Neuronal Death: Effects of Deferoxamine on Hemoglobin-Induced Neuronal Death , 2007, Stroke.
[29] Jean-Baptiste Michel,et al. Topological Determinants and Consequences of Adventitial Responses to Arterial Wall Injury , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[30] N. Weintraub,et al. Role of Oxidative Stress in the Pathogenesis of Abdominal Aortic Aneurysms , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[31] B. Vogt,et al. Rethinking the Triggering Inflammatory Processes of Chronic Periaortitis , 2006, Nephron Experimental Nephrology.
[32] A. Kontush,et al. Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis , 2006, Pharmacological Reviews.
[33] N. Brot,et al. Myeloperoxidase Impairs ABCA1-dependent Cholesterol Efflux through Methionine Oxidation and Site-specific Tyrosine Chlorination of Apolipoprotein A-I* , 2006, Journal of Biological Chemistry.
[34] Bin Lou,et al. Neutrophils activation can be diminished by apolipoprotein A-I. , 2005, Life sciences.
[35] Z. Lijun,et al. Role of macrophage and smooth muscle cell apoptosis in association with oxidized low-density lipoprotein in the atherosclerotic development , 2005, Modern Pathology.
[36] Michael Kinter,et al. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. , 2004, The Journal of clinical investigation.
[37] J. Michel,et al. Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus. , 2004, The American journal of pathology.
[38] K. Uchida,et al. Rapid formation of 4-hydroxy-2-nonenal, malondialdehyde, and phosphatidylcholine aldehyde from phospholipid hydroperoxide by hemoproteins. , 2004, Free radical biology & medicine.
[39] J. Graessler,et al. The protective effects of HDL and its constitutents against neutrophil respiratory burst activation by hypochlorite-oxidized LDL , 2004, Molecular and Cellular Biochemistry.
[40] J. Heinecke,et al. Lysine Residues Direct the Chlorination of Tyrosines in YXXK Motifs of Apolipoprotein A-I When Hypochlorous Acid Oxidizes High Density Lipoprotein* , 2004, Journal of Biological Chemistry.
[41] R. Dietz,et al. Intracellular superoxide induces apoptosis in VSMCs: Role of mitochondrial membrane potential, cytochrome c and caspases , 2002, Apoptosis.
[42] Per Eriksson,et al. Influence of intraluminal thrombus on structural and cellular composition of abdominal aortic aneurysm wall. , 2003, Journal of vascular surgery.
[43] A. Kontush,et al. Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[44] Gerard E. Dallal,et al. Change in &agr;1 HDL Concentration Predicts Progression in Coronary Artery Stenosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[45] J. Michel,et al. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. , 2002, The American journal of pathology.
[46] L. Oberley,et al. Oxidative Stress in Human Abdominal Aortic Aneurysms: A Potential Mediator of Aneurysmal Remodeling , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[47] M. Dubick,et al. Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[48] P. Jungers,et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. , 1998, Journal of immunology.
[49] Tzong-Shyuan Lee,et al. Colocalization of iron and ceroid in human atherosclerotic lesions. , 1998, Atherosclerosis.
[50] A. Nègre-Salvayre,et al. Oxidized LDLs induce massive apoptosis of cultured human endothelial cells through a calcium-dependent pathway. Prevention by aurintricarboxylic acid. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[51] J. Pincemail,et al. Decrease of Plasma Vitamin E (α‐Tocopherol) Levels in Patients with Abdominal Aortic Aneurysm , 1996, Annals of the New York Academy of Sciences.
[52] K. Yagi,et al. A simple fluorometric assay for lipoperoxide in blood plasma. , 1976, Biochemical medicine.
[53] J. Guichard,et al. Fine structural and cytochemical identification of microperoxisomes in developing human erythrocytic cells. , 1975, The American journal of pathology.